10 results match your criteria: "and Jules Bordet Institute[Affiliation]"
Prostate
February 2023
Division of Urology, Department of Surgical Sciences, Molinette Hospital, University of Turin, Turin, Italy.
Introduction: When performing targeted biopsy (TBx), the need to add systematic biopsies (SBx) is often debated. Aim of the study is to evaluate the added value of SBx in addition to TBx in terms of prostate cancer (PCa) detection rates (CDR), and to test the concordance between multiparametric magnetic resonance imaging (mpMRI) findings and fusion biopsy results in terms of cancer location.
Methods: We performed a retrospective, multicentric study that gathered data on 1992 consecutive patients who underwent elastic fusion biopsy between 2011 and 2020.
Prostate Cancer Prostatic Dis
September 2023
Department of Urology, Hôpital Universitaire de Bruxelles, Erasme hospital and Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
Background: Urinary microbiota is implicated in many diseases of the urinary tract. The aim of this study was to perform a systematic review of the role of urinary microbiota in prostatic diseases.
Methods: A PubMed/Medline search was undergone from inception through June 2022 for studies investigating urinary microbiota alterations in prostatic diseases, subdivided into benign prostatic hyperplasia (BPH), prostate cancer (PCa), and chronic prostatitis (CP).
Minerva Urol Nephrol
June 2021
Department of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy.
Introduction: High risk non-muscle invasive bladder cancer (NMIBC) is a recurring and potentially lethal disease. To date, with the exception of radical surgery, there are no validated strategies for patients not responding to intravesical BCG therapy. Immune checkpoint inhibitors (ICI) are currently being tested for BCG-resistant NMIBC.
View Article and Find Full Text PDFMed Mycol
November 2014
BCCM/IHEM fungal collection, Mycology and Aerobiology Laboratory, Scientific Institute of Public Health, Brussels, Belgium.
The identification of filamentous fungi by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) relies mainly on a robust and extensive database of reference spectra. To this end, a large in-house library containing 760 strains and representing 472 species was built and evaluated on 390 clinical isolates by comparing MALDI-TOF MS with the classical identification method based on morphological observations. The use of MALDI-TOF MS resulted in the correct identification of 95.
View Article and Find Full Text PDFClin Microbiol Infect
December 2013
Department of Microbiology, Saint-Pierre University Hospital and Jules Bordet Institute, Brussels, Belgium.
For septic patients, delaying the initiation of antimicrobial therapy or choosing an inappropriate antibiotic can considerably worsen their prognosis. This study evaluated the impact of rapid microbial identification (RMI) from positive blood cultures on the management of patients with suspected sepsis. During a 6-month period, RMI by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) was performed for all new episodes of bacteraemia.
View Article and Find Full Text PDFEur J Clin Microbiol Infect Dis
September 2012
Department of Microbiology, Saint-Pierre University Hospital and Jules Bordet Institute, rue Haute 322, 1000, Brussels, Belgium.
The identification of bacteria directly from positive blood cultures using matrix-assisted laser desorption-ionisation time-of-flight mass spectrometry (MALDI-TOF MS) is a new challenge to microbiologists. However, the protocols previously described are often difficult to implement in routine and comparisons are not always possible due to the variability of interpretative criteria. This study evaluated the analytical and practical performances of an in-house (IH) method, adapted from previous protocols, and the Sepsityper™ kit (Bruker Daltonics, Bremen, Germany).
View Article and Find Full Text PDFPediatr Infect Dis J
January 2012
Department of Microbiology, Saint-Pierre University Hospital and Jules Bordet Institute, Brussels, Belgium.
Background: Cryptosporidium outbreaks in day-care centers (DCCs) occur commonly. However, controlling spread of infection in these settings is difficult, and data about effectiveness of different control strategies are sparse. In this study, a Cryptosporidium outbreak in a large DCC located in Brussels is described with evaluation of hygienic and therapeutic interventions.
View Article and Find Full Text PDFProg Neurol Surg
July 2007
Gamma Knife Center, Erasme Hospital and Jules Bordet Institute, Brussels, Belgium.
Radiosurgery has recently emerged as a suitable treatment of pharmacologically resistant idiopathic trigeminal neuralgia. Results and complications of this treatment are related to parameters of the dosimetry, i.e.
View Article and Find Full Text PDFJ Clin Oncol
July 2002
Investigational Drug Branch for Breast Cancer, European Organization for the Research and Treatment of Cancer Data Center, and Jules Bordet Institute, Brussels, Belgium.
Purpose: To compare the efficacy and tolerability of the combination of doxorubicin and paclitaxel (AT) with a standard doxorubicin and cyclophosphamide (AC) regimen as first-line chemotherapy for metastatic breast cancer.
Patients And Methods: Eligible patients were anthracycline-naive and had bidimensionally measurable metastatic breast cancer. Two hundred seventy-five patients were randomly assigned to be treated with AT (doxorubicin 60 mg/m(2) as an intravenous bolus plus paclitaxel 175 mg/m(2) as a 3-hour infusion) or AC (doxorubicin 60 mg/m(2) plus cyclophosphamide 600 mg/m(2)) every 3 weeks for a maximum of six cycles.
Eur Urol
May 1995
Free University Brussels, Saint-Pierre Hospital, and Jules Bordet Institute, Brussels, Belgium.
Nephrectomy is a debilitating procedure because of the trauma to the abdominal wall. Laparoscopy could be a solution in this matter. Four patients underwent laparoscopic nephrectomy.
View Article and Find Full Text PDF